Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue $ 128 $ 29 $ 172 $ 34
Costs and expenses        
Cost of revenue, exclusive of depreciation and amortization shown separately below 54 5 90 7
Depreciation and amortization 273 564 798 1,730
General and administrative 2,113 2,850 7,218 9,080
Total costs and expenses 2,440 3,419 8,106 10,817
Operating loss from continuing operations (2,312) (3,390) (7,934) (10,783)
Other income (expense)        
Interest income 193 361
Unrealized gain on short-term investments 109 109
Interest expense (1) (219) (236) (989)
Financing costs (90) (1,239)
Other income, net 46 64 648 844
Change in fair value of derivative liability 4 1 210
Total other income (expense), net 347 (151) 793 (1,174)
Net loss from continuing operations (1,965) (3,541) (7,141) (11,957)
Loss from discontinued operations, net of tax (168) (7,122)
Net loss (1,965) (3,709) (7,141) (19,079)
Series C Preferred Stock dividend payable (99) (240)
Deemed dividend due to redemption of Series C Preferred Stock (652)   (652)  
Deemed dividend due to warrant reset (164)
Net loss to common stockholders $ (2,716) $ (3,709) $ (8,033) $ (19,243)
Loss per share from continuing operations- basic $ (3.82) $ (130.64) $ (17.16) $ (516.80)
Loss per share from continuing operations- diluted (3.82) (130.64) (17.16) (516.80)
Loss per share from discontinuing operations- basic 0.00 (6.20) 0.00 (303.66)
Loss per share from discontinuing operations- diluted $ 0.00 $ (6.20) $ 0.00 $ (303.66)
Weighted average number of common shares outstanding - basic 710,106 27,104 468,252 23,454
Weighted average number of common shares outstanding - diluted 710,106 27,104 468,252 23,454